: Article ID 100767 refers to a 2025 study on Aberrant FGF signaling in medulloblastoma tumors.

: Recall number 100767 is a Class 2 device recall for the VITEK 2 XL system issued by the FDA .

: Report 100767 is a certified filing from the Louisiana Board of Ethics .